Such DCs have been shown to contribute to tumor angiogenesis (118), the development and recruitment of immunosuppressive Tregs (119–121), and the direct suppression of CD4+ and CD8+ T cells (122, 123). The gene discussed is CD8A; the disease is neoplasm.